Jubilant bhartia foundation - Latest News Update, Information, Photos & Videos on Jubilant bhartia foundation at Lokmat Times

Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment through its distribution network.Jubilant's 24-hour helpline will enhance access to JUBI-R during these pandemic times where timely access to the drug may prove critical to treatment outcomes.In order to increase its accessibility to patients below the poverty line and to frontline paramedical staff, Jubilant Bhartia Foundation -- a not-for-profit orgsation of Jubilant Group -- is launching programmes aimed at the distribution of the drug.In May, Jubilant entered into a non-exclusive licensing agreement with Gilead Sciences Inc that granted it the right to register, manufacture and sell investigational drug Remdesivir in 127 countries including India.Remdesivir is the only anti-viral drug that has received emergency use authorisation by the US Food and Drug Administration for treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe disease."We have launched the product at affordable prices and strive to make it available in sufficient quantities to meet the high demand for the drug in the Indian market and in other countries," said Chairman and Managing Director Shyam S Bhartia and Co-Chairman Hari S Bhartia.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Jubilant Bhartia Foundation, NewsFOLLOW

Jubilant bhartia foundation, Latest News

Business :Jubilant launches Remdesivir in India for treatment of COVID-19

Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment through ...